Janice A. Egeland, Ph.D., professor emerita of psychiatry and behavioral sciences, and collaborators at three other institutions have identified what may be the molecular pathway underlying bipolar I (manic depressive) disorder (BPI), a breakthrough that could lead to better drugs for treating BPI, as well as depression and other related mood disorders. Their findings have been published online in Nature Molecular Psychiatry.
Novel Stem Cell Trial for Cervical Spinal Cord Injury to Start with the Miller School’s Miami Project
A novel clinical trial using human neural stem cells for the treatment of cervical spinal cord injury is beginning at the Miller School of Medicine. Allan D. Levi, M.D., Ph.D., professor and Robert M. Buck Distinguished Chair in Neurological Surgery, is the principal investigator of the Pathway Study, which is the first clinical study of its kind.
Two generous contributions totaling $4.675 million are being made to the University of Miami from the 2008 Revocable Trust of Gail S. Posner, who was a longtime resident of Miami Beach. These contributions will go a long way in helping both breast cancer patients and those battling substance abuse.
David J. Lee, Ph.D., professor of public health sciences, has been appointed to the NIH National Deafness and Other Communication Disorders Advisory Council for a four-year term.
While the typical preteen or adolescent can be found playing sports or video games after school, more than 1.3 million spend their free time caring for a family member. These “caregiving youth” are a hidden population who are at risk of school failure and poor health due to the chronic physical and emotional stress of their responsibilities at home, said Julia Belkowitz, M.D.